Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Toyobo Enters Contracted Cell Manufacturing Business

Filed Under: Innovation, Pharma, Products Tagged With: , , , ,

Toyobo Co. Ltd. (TYO:3101) is starting up a new business for contracted manufacturing of tissue-engineered cells. The company has received…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Toyobo Develops World's Strongest PE Fiber
Toyobo Develops World's Strongest PE Fiber
Toyobo Targets Animal Health Care, Athlete Monitoring Sectors With Conductive Film for Wearables
Toyobo Targets Animal Health Care, Athlete Monitoring…
Toyobo Polymerizes 100% Bio-Based PET Resin
Toyobo Polymerizes 100% Bio-Based PET Resin
Gunze Targets Regenerative Medicine Market With Bioabsorbable Scaffold for Blood Vessels
Gunze Targets Regenerative Medicine Market With…
Toyobo Moves in Quick Succession to Ramp up Production of High-Strength PE Fibers
Toyobo Moves in Quick Succession to Ramp up Production of…